OverviewSuggest Edit

SQZ Biotech is a company that develops transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. It uses its technology, Cell Squeeze, to physically squeeze cells through a microfluidic chip, temporarily opening the cell membrane and enabling biologic material of interest, or cargo, to diffuse into the cell. This technology allows the company to create a pipeline of product candidates for different diseases.

TypePublic
Founded2013
HQWatertown, MA, US
Websitesqzbiotech.com
Employee Ratings3.2

Latest Updates

Employees (est.) (Jul 2020)101
Revenue (FY, 2020)$21 M(+5%)
Share Price (Jun 2021)$13.6
Cybersecurity ratingBMore

Key People/Management at SQZ Biotech

Armon Sharei

Armon Sharei

Chief Executive Officer and Founder
Teri Loxam

Teri Loxam

Chief Financial Officer
Oliver Rosen

Oliver Rosen

Chief Medical Officer
Howard Bernstein

Howard Bernstein

Chief Scientific Officer
James Douberley

James Douberley

Director Of Operations
Larry Knopf

Larry Knopf

General Counsel
Show more

SQZ Biotech Office Locations

SQZ Biotech has an office in Watertown
Watertown, MA, US (HQ)
200 Arsenal Yards Blvd
Show all (1)

SQZ Biotech Financials and Metrics

SQZ Biotech Revenue

SQZ Biotech's revenue was reported to be $21 m in FY, 2020
USD

Revenue (Q1, 2021)

5.5m

Net income (Q1, 2021)

(15.4m)

EBIT (Q1, 2021)

(15.4m)

Market capitalization (4-Jun-2021)

378.1m

Closing stock price (4-Jun-2021)

13.6

Cash (31-Mar-2021)

204.9m

EV

217.9m
SQZ Biotech's current market capitalization is $378.1 m.
Annual
USDFY, 2018FY, 2019FY, 2020

Revenue

12.7m20.1m21.0m

Revenue growth, %

59%

General and administrative expense

8.7m18.3m20.5m

R&D expense

24.4m36.1m51.5m
Half Year
USDH1, 2019H1, 2020

Revenue

9.7m12.4m

General and administrative expense

7.1m9.5m

R&D expense

17.8m23.9m

Operating expense total

25.0m33.4m
Quarterly
USDQ3, 2020Q1, 2021

Revenue

6.1m5.5m

General and administrative expense

4.6m6.1m

R&D expense

13.9m14.7m

Operating expense total

18.5m20.9m
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

59.6m39.3m170.4m

Accounts Receivable

865.0k1.9m1.9m

Prepaid Expenses

4.6m

Current Assets

108.8m101.8m176.8m
Quarterly
USDQ2, 2020Q3, 2020Q1, 2021

Cash

114.6m107.1m204.9m

Accounts Receivable

1.8m1.9m25.0k

Prepaid Expenses

1.9m6.2m

Current Assets

134.0m118.9m211.1m
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

(19.2m)(32.2m)(50.5m)

Depreciation and Amortization

1.1m1.4m1.3m

Accounts Payable

434.0k1.7m100.0k

Cash From Operating Activities

21.1m(33.5m)(43.2m)
Quarterly
USDQ2, 2019Q2, 2020Q3, 2020Q1, 2021

Net Income

(14.1m)(20.6m)(32.9m)(15.4m)

Depreciation and Amortization

657.0k677.0k1.0m327.0k

Accounts Payable

1.8m(25.0k)(846.0k)572.0k

Cash From Operating Activities

(9.5m)(8.9m)(23.9m)(20.6m)
USDFY, 2018

Revenue/Employee

153.6k

Financial Leverage

-2.7 x
Show all financial metrics

SQZ Biotech Operating Metrics

Q2, 2020

Pre-Clinical Phase Products

10

Phase I Trials Products

1
Show all operating metrics

SQZ Biotech Acquisitions / Subsidiaries

Company NameDateDeal Size
SQZ Biotechnologies Security Corporation

SQZ Biotech Revenue Breakdown

Embed Graph

SQZ Biotech revenue breakdown by business segment: 96.1% from Collaboration and 3.9% from Other

SQZ Biotech Cybersecurity Score

Cybersecurity ratingPremium dataset

B

86/100

SecurityScorecard logo

SQZ Biotech Online and Social Media Presence

Embed Graph

SQZ Biotech News and Updates

SQZ Biotech Announces Key Executive and Board of Directors Appointments

WATERTOWN, Mass., Sept. 27, 2018 /PRNewswire/ -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the appointment of Volker Herrmann, MD, MBA, as Chief Operating Officer and President and Pushkal Garg, MD, to the ...

SQZ Biotech pulls in funding

Massachusetts-based SQZ Biotech, a preclinical stage biotechnology company, has raised an undisclosed amount of funding. The investor was JDRF T1D Fund.

SQZ Biotech Blogs

SQZ Therapeutics pushes forward with its method to squeeze drugs into cells

The post SQZ Therapeutics pushes forward with its method to squeeze drugs into cells appeared first on SQZ Biotech.

SQZ Biotech to Present at Investor Conferences in November

The post SQZ Biotech to Present at Investor Conferences in November appeared first on SQZ Biotech.

Cell engineering with microfluidic squeezing preserves functionality of primary immune cells in vivo

The post Cell engineering with microfluidic squeezing preserves functionality of primary immune cells in vivo appeared first on SQZ Biotech.

SQZ Biotech Announces PNAS Publication Demonstrating Significant Advantages of Its Cell Squeezing Technology for the Development of Cell-Based Therapeutics

The post SQZ Biotech Announces PNAS Publication Demonstrating Significant Advantages of Its Cell Squeezing Technology for the Development of Cell-Based Therapeutics appeared first on SQZ Biotech.

SQZ play: Roche doubles down on a $1.37B-plus deal for a new approach to immuno-oncology out of Bob Langer’s lab

The post SQZ play: Roche doubles down on a $1.37B-plus deal for a new approach to immuno-oncology out of Bob Langer’s lab appeared first on SQZ Biotech.

Roche and SQZ Biotech Expand R&D Pact in Pursuit of New Cancer Drugs

The post Roche and SQZ Biotech Expand R&D Pact in Pursuit of New Cancer Drugs appeared first on SQZ Biotech.
Show more

SQZ Biotech Frequently Asked Questions

  • When was SQZ Biotech founded?

    SQZ Biotech was founded in 2013.

  • Who are SQZ Biotech key executives?

    SQZ Biotech's key executives are Armon Sharei, Teri Loxam and Oliver Rosen.

  • How many employees does SQZ Biotech have?

    SQZ Biotech has 101 employees.

  • What is SQZ Biotech revenue?

    Latest SQZ Biotech annual revenue is $21 m.

  • What is SQZ Biotech revenue per employee?

    Latest SQZ Biotech revenue per employee is $207.9 k.

  • Who are SQZ Biotech competitors?

    Competitors of SQZ Biotech include Ultivue, Onconova Therapeutics and Cleveland BioLabs.

  • Where is SQZ Biotech headquarters?

    SQZ Biotech headquarters is located at 200 Arsenal Yards Blvd, Watertown.

  • Where are SQZ Biotech offices?

    SQZ Biotech has an office in Watertown.

  • How many offices does SQZ Biotech have?

    SQZ Biotech has 1 office.